Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radionuclides. Found 2 abstracts

Adams GP, Simmons HH, Yuan Q, Marasco W, Mehta S. Anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer. 2005 Jul 08;:80 pp.
Adams GP, Horak EM, Weiner LM, Marks JD. Bispecific scFv antibody molecules capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer. 2004 Apr 04;:57 pp.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radionuclides

Ovary Antitumor agents Prostate gland Human Bacteriophage Cosmids Mammary gland Radionuclides Diagnosis (cancer Testis (treatment of Radiation (external beam Imaging (tumor unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (RIP (ribosome-inactivating protein)-antibody conjugated with unclassified) Epidermal growth factor receptors Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (HER4 unclassified) neu Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment unclassified) Peptides Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (linker mullerian inhibiting substance receptor MISIIR immunoconjugate human cancer Animal tissue Blood plasma Blood BSU (Biological study Gene Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (for antibody Epitopes unclassified) Antibodies and Immunoglobulins Role: BSU (Biological study-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (labeled Urine treatment of Carcinoma (cervix Signal transduction (inhibitors unclassified) Hormone receptors Role: BSU (Biological study-BIOL (Biological study) (Mullerian-inhibiting hormone-type II PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (anti-MISIIR unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (momordins-antibody conjugated with Labels Abrins Viral vectors (bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) Diagnosis (immunodiagnosis of EGFR protein family for diagnosis and treatment of cancer) DNA sequences Testis Plasmids Positron-emission tomography Intestine (colon Drug delivery systems (carriers Gene therapy Drugs Linking agents carcinoma Uterus (cervix-treatment of Phage display library Fusion proteins Imaging (NMR Cytotoxic agents magnetic Spheres (beads-antibody conjugated with unclassified) Proteins Role: BSU (Biological study-BIOL (Biological study) (PAP (pokeweed antiviral protein)-antibody conjugated with Gamma ray (emitters or (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (antibody conjugated with Samples (biol or biopsy BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (fragments-scFv anti-Mullerian inhibiting substance type II recep Viral vectors Molecules (effector Uterus (endometrium Blood cell Stomach Drug delivery systems (immunoconjugates Lung anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) unclassified) Toxins Role: BSU (Biological study-BIOL (Biological study) (diphtheria-antibody conjugated with Salivary gland Pancreas Adoptive immunotherapy Ricins Protein sequences bispecific antibody scFv EGFR family member cancer diagnosis therapy Epidermal growth factor receptors Ligands Scintigraphy unclassified) Growth factor receptors Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (erbB-3 Imaging agents cDNA sequences (anti-Mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer) site lacking Post-translational processing (proteolytic BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (bispecific unclassified) Toxins Role: BSU (Biological study-DGN (Diagnostic use)-THU (Therapeutic use)-BIOL (Biological study)-USES (Uses) (cytotoxins Genetic vectors Liposomes Peptide nucleic acids bispecific scFv antibody mols capable of binding to different epitopes of EGFR protein family for diagnosis and treatment of cancer) antibody conjugated with Drug delivery systems (prodrugs Lung (toxicity Plasmid vectors Chemotherapy (antibody conjugated with BSU (Biological study Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-unclassified)-DGN (Diagnostic use)-PRP (Properties)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (bispecific scFv antibody Imaging agents (NMR contrast Molecular cloning Drug delivery systems (liposomes Uterus (cervix Immunoassay (immunohistochem antibody conjugated with Pseudomonas (exotoxin PRP (Properties) Antibodies and Immunoglobulins Role: BPN (Biosynthetic preparation)-THU (Therapeutic use)-BIOL (Biological study)-PREP (Preparation)-USES (Uses) (single chain-Fv-anti-MISIIR Chemotherapy Animal cell bispecific scFv antibody mols capable of binding to different epitopes aspirate Mammary gland (nipple
Last updated on Tuesday, July 07, 2020